Skip to main content
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.91
-0.35 (-5.59%)
At close: Nov 12, 2026, 4:00 PM EST
5.91
0.00 (0.00%)
After-hours: Nov 12, 2026, 4:15 PM EST

Bolt Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1510204349183
Market Cap Growth
--48.75%-51.84%-13.15%-73.20%-
Enterprise Value
-2-15-56-99-5
Last Close Price
6.265.4710.7022.4026.0098.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1.362.665.408.55145.00
PB Ratio
-0.400.360.380.280.73
P/TBV Ratio
-0.400.360.380.280.73

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-0.28----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.710.870.440.180.130.10
Net Debt / Equity Ratio
0.32-0.17-0.39-0.73-0.85-0.65
Net Debt / EBITDA Ratio
-0.150.140.331.101.651.77
Net Debt / FCF Ratio
-0.130.110.361.181.862.73
Asset Turnover
0.080.100.060.040.020.01
Quick Ratio
2.243.383.065.037.318.73
Current Ratio
2.613.593.215.177.478.87
Return on Equity (ROE)
-111.65%-79.75%-74.28%-48.69%-41.79%-71.52%
Return on Assets (ROA)
-30.73%-27.68%-32.88%-24.57%-21.08%-32.74%
Return on Capital Employed (ROCE)
-87.70%-71.70%-81.50%-54.70%-44.10%-32.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
--318.00%-308.19%-162.73%-179.94%-53.96%
FCF Yield
-194.84%-380.37%-299.47%-163.99%-160.25%-32.52%
Buyback Yield / Dilution
8.42%2.06%-0.98%-1.21%-12.54%-1479.05%
SEC Filings: 10-K · 10-Q